- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/14 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 215/14
Total number of patents in this class: 469
10-year publication summary
|
28
|
31
|
39
|
34
|
33
|
25
|
21
|
16
|
23
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4792 |
22 |
| Gilead Sciences, Inc. | 2145 |
19 |
| Merck Patent GmbH | 5732 |
8 |
| Neurocrine Biosciences, Inc. | 437 |
7 |
| Merck Sharp & Dohme LLC | 3717 |
7 |
| Novartis AG | 10462 |
6 |
| Agios Pharmaceuticals, Inc | 220 |
6 |
| Nissan Chemical Industries, Ltd. | 1680 |
6 |
| Santen Pharmaceutical Co., Ltd. | 594 |
6 |
| Janssen Pharmaceutica N.V. | 3301 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 863 |
5 |
| University College Dublin, National University of Ireland, Dublin | 356 |
5 |
| Allergan, Inc. | 2260 |
4 |
| Centre National de La Recherche Scientifique | 10820 |
4 |
| Alkermes Pharma Ireland Limited | 256 |
4 |
| Ardelyx, Inc. | 114 |
4 |
| Cadila Healthcare Limited | 305 |
4 |
| Imago Biosciences, Inc. | 38 |
4 |
| Toyama Chemical Co., Ltd. | 96 |
4 |
| The Wistar Institute of Anatomy and Biology | 467 |
4 |
| Other owners | 335 |